Capital World Investors’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
B
CS
CH
Capital World Investors's CLLS Position: Q1 2023 in Review
Capital World Investors sold out of Cellectis (CLLS) in Q1 2023, closing a stake of 250,000 shares — an estimated $525K sold.
Capital World Investors first reported a position in CLLS in Q2 2018 and held it in 19 quarters. The position peaked at $24.8M in Q2 2018. 33 funds tracked by Wall St. Rank hold CLLS as of Q1 2023.
- Capital World Investors reported no remaining Cellectis position as of Q1 2023 after selling out during the quarter.
- Capital World Investors sold 250,000 Cellectis shares in Q1 2023, an estimated $525K.
- Capital World Investors first reported a position in Cellectis in Q2 2018 and held it in 19 quarters.
- Capital World Investors's Cellectis position peaked at $24.8M in Q2 2018.
- 33 funds tracked by Wall St. Rank held Cellectis as of Q1 2023.
Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.